Tag Archives: European Commission

Europe: Health Commissioner's Sudden Exit Spotlights Regulation Crisis

By Guest Blogger | Published: October 24, 2012
The sudden departure of EC Health Commissioner John Dalli tops an already difficult year for the European pharma regulators, writes Reflector. The abrupt departure of Health Commissioner John Dalli in highly controversial circumstances comes on top of an extremely difficult year for the European Medicines Agency (EMA). At the same time, one of the main supervisory bodies [...]
Posted in Strategy | Also tagged , , | Leave a comment

Patients Wade into the European Pricing Debate

By Guest Blogger | Published: July 30, 2012
Patient groups are a growing force, not just in the debate around tactical areas of medical specialities, but also on the vital question of pricing and reimbursement rules. But will their voices be heard? Reflector reports. An important third party is struggling to make its voice heard in European pharma discussions. Drug pricing is not just [...]
Posted in Europe, Global, Guest Blog, Regulatory, healthcare, pricing | Also tagged , , , , | Leave a comment

"Data is the New Oil": Open Access to Sweep Europe?

By Julian Upton | Published: July 18, 2012
The European Commission has followed the UK government’s plans to make all publicly funded scientific research available for free, announcing that it will improve access to scientific information in Europe. The UK’s proposal, on the table since last year, was confirmed on Monday by Universities and Science Minister David Willetts. The scheme will make research papers [...]
Posted in Europe, Guest Blog | Also tagged , , , , , , | 1 Comment

EU Health Commissioner Emerges from the Dark

By Julian Upton | Published: December 13, 2010
After a period of near invisibility, the EU’s health commissioner John Dalli has begun to make some higher profile appearance. Pharm Exec’s Europe correspondent Reflector assesses how these have been received by the pharma industry. Just before the holiday break, John Dalli, the European Union’s unobtrusive commissioner for health, has at last emerged from obscurity to [...]
Posted in Europe, Global, Guest Blog, Regulatory | Also tagged , | 1 Comment

Europe: Resisting the Anticompetitive Crusade

By Julian Upton | Published: July 23, 2010
It’s been another rocky few weeks for pharma in Europe. Particularly for big brand name companies. But necessity is proving the mother of invention, says Pharm Exec’s Brussels correspondent, Reflector. AstraZeneca suffered a serious setback at the start of July when the European General Court ruled that it had illegally prevented generic competition. The case dates [...]
Posted in Strategy | Also tagged , , , , , , | Leave a comment